Last Updated on August 8, 2021 by The Health Master
In an effort to curb the C-19 pandemic menace the Government of India has approved the single-dose vaccine from Johnson & Johnson for emergency use in the country. This is the fifth Emergency Use Authorisation (EUA) vaccine India is approving to fight the pandemic.
Union minister of health and family welfare, Mansukh Mandaviya, in his twitter account announced, “India expands its vaccine basket! Johnson and Johnson’s single-dose C-19 vaccine is given approval for Emergency Use in India”. This will further boost India’s collective fight against the pandemic, he added.
According to earlier reports, the company is expected to launch the vaccine in India in collaboration with Hyderabad-based Biological E Ltd.
The Emergency Use Authorization is a regulatory mechanism to allow the use of vaccines and medicines to prevent and/or reduce the impact of life-threatening diseases or conditions as caused by C-19.
However, before grant of the EUA, rigorous assessments of laboratory and clinical trial data, including data on quality, safety, production of protective antibodies and efficacy is conducted, said the ministry. Full licensure is obtained when the manufacturer submits the complete data. EUA by Indian regulators is aligned with global guidelines.
According to reports, the company received the approval a day after it has applied with the India government. The vaccine has shown 85 per cent efficacy and showed protection against the disease-related hospitalisation and mortality from 28 days after the vaccination, it was said.
The vaccines that are available in India are Covishield (AstraZeneca’s vaccine manufactured by Serum Institute of India), Covaxin (manufactured by Bharat Biotech Limited), and Russian vaccine Sputnik-V which will be supplied by Dr Reddy’s Laboratories. Another vaccine approved in the country is the RNA-based vaccine from Moderna.
The difference with Johnson & Johnson’s vaccine is that it is a single-dose jab compared to the others which need two doses in specific intervals.
According to the international vaccine alliance GAVI, it is a viral vector vaccine using a version of an adenovirus which causes mild cold or flu symptoms in people. The company has modified the virus to include DNA that codes for the spike protein on the SARS-CoV-2 virus.
The minister said that in the month of July, the daily average vaccine dose adminstered in the country increased to 43.41 lakh compared to 39.89 lakh in June, 2021. The total number of vaccine doses administered during the month was 13.45 crore as compared to 11.97 crore in the previous month.